Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05177770
Title Study of SRF617 With AB928 (Etrumadenent) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Surface Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Miami - Sylvester Comprehensive Cancer Center Miami Florida 33136 United States Details
University of Michigan Health System Ann Arbor Michigan 48109 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 84119 United States Details
UT Southwestern Dallas Texas 75390 United States Details
START South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
START Mountain Region, Utah Cancer Specialists West Valley City Utah 84119 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
BC Cancer - The Vancouver Centre Vancouver British Columbia V5Z 4E6 Canada Details
Université de Montreal - Centre de Recherche du Centre Hospitalier de L'Université de Montreal (CRCHUM) Montréal Quebec H2X 0A9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field